Antipyrine and Benzocaine

ANTIPYRINE AND BENZOCAINE — antipyrine and benzocaine solution
REMEDYREPACK INC.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

DESCRIPTION

Antipyrine and Benzocaine Otic Solution is an otic solution containing Antipyrine, Benzocaine, Oxyquinoline Sulfate, and Anhydrous Glycerin for use in the ear. The solution congeals at 0°C (32°F), but returns to normal consistency, unchanged, at room temperature.

Antipyrine is an analgesic with local anesthetic action, it is chemically 2,3-dimethyl-1-phenyl-3-pyrazolin-5-one. The active ingredient is represented by the structural formula:

MM1

C11 H12 N2 O
Mol. Wt. 188.22

Antipyrine occurs as colorless crystals or white powder, has a slightly bitter taste and is soluble in water and alcohol.

Benzocaine is a local anesthetic. It is chemically ethyl p -aminobenzoate or Benzoic acid, 4-amino-, ethyl ester. The active ingredient is represented by the structural formula:

MM2
(click image for full-size original)

C9 H11 NO2
Mol. Wt. 165.19

It occurs as white crystals or white crystalline powder and is slightly soluble in water and soluble in organic solvents.

Each mL Contains: ACTIVES: Antipyrine 54 mg (5.4%), Benzocaine 14 mg (1.4%); INACTIVES: Glycerin, Oxyquinoline Sulfate.

CLINICAL PHARMACOLOGY

Antipyrine and Benzocaine Otic Solution combines the hygroscopic property of anhydrous glycerin with the analgesic action of antipyrine and benzocaine to relieve pressure, reduce inflammation and congestion, and to alleviate pain and discomfort in acute otitis media.

Antipyrine and Benzocaine Otic Solution does not blanch the tympanic membrane or mask the landmarks and, therefore, does not distort the otoscopic picture.

INDICATIONS & USAGE

Acute Otitis media of various etiologies

-prompt relief of pain and reduction of inflammation in the congestive and serous stages.

-adjuvant therapy during systemic antibiotic administration for resolution of the infection.

Because of the close anatomical relationship of the eustachian tube to the nasal cavity, otitis media is a frequent problem, especially in children in whom the tube is shorter, wider, and more horizontal than in adults.

Removal of Cerumen

-facilitates the removal of excessive or impacted cerumen.

CONTRAINDICATIONS

The product is contraindicated in any person with hypersensitivity to any of the components or substances related to them. This product is contraindicated in the presence of spontaneous perforation of the tympanic membrane or discharge.

WARNINGS

FOR USE IN EARS ONLY- NOT FOR USE IN EYES

Discontinue promptly if sensitization or irritation occurs.

PRECAUTIONS

Avoid contaminating the dropper with material from the ear, fingers or other source.

No long term studies have been conducted.

Category C. Animal reproduction studies have not been conducted with Antipyrine and Benzocaine Otic Solution. It is also not known whether Antipyrine and Benzocaine Otic Solution can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Antipyrine and Benzocaine Otic Solution should be given to a pregnant woman only if clearly needed.

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Antipyrine and Benzocaine Otic Solution is administered to a nursing woman.

DOSAGE & ADMINISTRATION

Acute otitis media: Instill Antipyrine and Benzocaine Otic Solution, permitting the solution to run along the wall of the ear canal until it is filled. Avoid touching the ear with dropper. Then moisten a cotton pledget with Antipyrine and Benzocaine Otic Solution and insert into meatus. Repeat every one to two hours until pain and congestion are relieved.

Removal of Cerumen:

Before: Instill Antipyrine and Benzocaine Otic Solution three times daily for two or three days to help detach cerumen from wall of ear canal and facilitate removal.

After: Antipyrine and Benzocaine Otic Solution is useful for drying out the ear canal or relieving discomfort.

Before and after removal of cerumen, a cotton pledget moistened with Antipyrine and Benzocaine Otic Solution should be inserted into the meatus following instillation.

Use of Dropper:

Remove cap from bottle and discard. Remove dropper from package. Place dropper in bottle and use as directed. After use, do not rinse dropper and place dropper in bottle and close tightly.

NOTE: Do not use if solution is brown or contains a precipitate.

DISCARD THIS PRODUCT SIX MONTHS AFTER DROPPER IS FIRST PLACED IN THE DRUG SOLUTION.

HOW SUPPLIED

Antipyrine and Benzocaine Otic Solution USP is supplied in an amber glass bottle with a dropper in the following size:

10 mL — Prod. No. 12409

MM3
(click image for full-size original)

Storage: Store between 15°-25°C (59°- 77°F). PROTECT FROM LIGHT AND HEAT.


KEEP OUT OF REACH OF CHILDREN.


Revised February 2008

Bausch & Lomb Incorporated
Tampa, FL 33637
©Bausch & Lomb Incorporated

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION

DRUG: Antipyrine and Benzocaine

GENERIC: Antipyrine and Benzocaine

DOSAGE: SOLUTION

ADMINSTRATION: AURICULAR (OTIC)

NDC: 61786-328-08

ACTIVE INGREDIENT(S):

  • ANTIPYRINE 54mg in 1mL
  • BENZOCAINE 14mg in 1mL

INACTIVE INGREDIENT(S):

  • GLYCERIN
  • OXYQUINOLINE SULFATE

PACKAGING: 10 mL in 1 BOTTLE, DROPPER

MM4
(click image for full-size original)
MM5
(click image for full-size original)
ANTIPYRINE AND BENZOCAINE
antipyrine and benzocaine solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:61786-328(NDC:24208-561)
Route of Administration AURICULAR (OTIC) DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ANTIPYRINE (ANTIPYRINE) ANTIPYRINE 54 mg in 1 mL
BENZOCAINE (BENZOCAINE) BENZOCAINE 14 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
GLYCERIN
OXYQUINOLINE SULFATE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:61786-328-08 10 mL in 1 BOTTLE, DROPPER None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 06/08/2015
Labeler — REMEDYREPACK INC. (829572556)

Revised: 06/2015 REMEDYREPACK INC.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.